A 2-step phase I study evaluating the safety of (neo-)adjuvant cisplatin-pemetrexed and stereotactic radiotherapy (SRT) for patients with stage IB non-small-cell lung cancer (NSCLC).
Phase of Trial: Phase I
Latest Information Update: 29 Apr 2014
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 16 Jun 2009 New trial record